Sarah Ringuette

Sarah Ringuette, MPH, RAC has over 20 years of experience in regulatory affairs and strategy. Sarah has held various leadership positions at top pharmaceutical companies such as Exelixis, Curis, Agenus, and Elevation Oncology. Sarah'smost recent role was as the Vice President of Regulatory Strategy at Exelixis. Prior to that, they served as the Vice President of Regulatory Affairs at Curis and as the Vice President and Head of Regulatory at Agenus. Sarah also has experience as the Vice President and Head of Regulatory Affairs at Elevation Oncology. Before joining these companies, Sarah worked at Biohaven Pharmaceuticals, where they served as the Executive Director and later the Director of Regulatory Affairs. Sarah was the Global Regulatory Lead at Alexion Pharmaceuticals and held several roles at Bristol-Myers Squibb, including Global Regulatory Team Lead and Regulatory Documentation Lead. Sarah started their career as an Associate Director at Bristol-Myers Squibb, where they specialized in protocol management. Throughout their career, Sarah has been involved in a wide range of therapeutic areas, including neurology, oncology, and infectious diseases.

Sarah Ringuette, MPH, RAC has a Master of Public Health (MPH) degree in Epidemiology from The Johns Hopkins University, which they obtained between 2000 and 2004. Sarah also holds a Bachelor of Science (B.S.) degree from The George Washington University School of Medicine and Health Sciences, earned from 1993 to 1997. In terms of certifications, Sarah is a RAPS member and has obtained various regulatory affairs certifications, including RAC-US, a Regulatory Affairs Certificate: Dual, and a Regulatory Affairs Certificate: Medical Devices. The specific dates for these certifications are available. Additionally, they obtained the RAC certificate from RAPS in 2018, and their ongoing education includes pursuit of an unspecified RAC degree from RAPS starting in 2018.